Ongoing Studies

The ACHIEVE-4 study will test how safe and well an investigational medicine works for people with type 2 diabetes and excess weight who are at risk for heart disease or stroke compared to insulin therapy.

A study to access the efficacy of recorilant for the treatment of hypercortisolism in patients with cortisol-secreting adrenal adenomas or hyperplasia, based on glycemic and blood pressure control compared with placebo 

The objective of this study is to provide palopegteriparatide, an investigational PTH replacement therapy in an expanded access setting for patients with hypoparathyroidism

who have previously received PTH-treatment and that have a clear unmet medical need that cannot adequately be treated by a commercial product or a clinical trial.

This study will evaluate the efficacy and safety of Armour Thyroid treatment compared with synthetic T4 in subjects who have primary hypothyroidism and are currently stabilized on synthetic T4 treatment.

An observational, non-interventional safety study to investigate long-term safety of Sogroya® (somapacitan) in adults with growth hormone deficiency (AGHD) under routine clinical practice.